Cellular basis for blunted volume expansion natriuresis in experimental nephrotic syndrome.
Authors:
- C QiuCQC Qiu
- W P MuldowneyWMW P Muldowney
- W Z YingWYW Z Ying
- D G GardnerDGD G Gardner
- M H HumphreysMHM H Humphreys
Open Access
- 1 October 1992
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 90 (4) , 1302-1312
Abstract
Experimental nephrotic syndrome results in sodium retention, reflecting, at least in part, an intrinsic defect in renal sodium handling in the distal nephron. We studied the relationships among plasma atrial natriuretic peptide (ANP) concentration, sodium excretion (UNaV), and urinary cyclic GMP excretion (UcGMPV) in vivo, and the responsiveness of isolated glomeruli and inner medullary collecting duct (IMCD) cells to ANP in vitro, in rats with adriamycin nephrosis (6-7 mg/kg body weight, intravenously). 3-5 wk after injection, rats were proteinuric and had a blunted natriuretic response to intravenous infusion of isotonic saline, 2% body weight given over 5 min. 30 min after onset of the infusion, plasma ANP concentrations were elevated in normals and were even higher in nephrotics. Despite this, nephrotic animals had a reduced rate of UcGMPV after the saline infusion, and accumulation of cGMP by isolated glomeruli and IMCD cells from nephrotic rats after incubation with ANP was significantly reduced compared to normals. This difference was not related to differences in binding of 125I-ANP to IMCD cells, but was abolished when cGMP accumulation was measured in the presence of 10(-3) M isobutylmethylxanthine or zaprinast (M&B 22,948), two different inhibitors of cyclic nucleotide phosphodiesterases (PDEs). Infusion of zaprinast (10 micrograms/min) into one renal artery of nephrotic rats normalized both the natriuretic response to volume expansion and the increase in UcGMPV from the infused, but not the contralateral, kidney. These results show that, in adriamycin nephrosis, blunted volume expansion natriuresis is associated with renal resistance to ANP, demonstrated both in vivo and in target tissues in vitro. The resistance does not appear related to a defect in binding of the peptide, but is blocked by PDE inhibitors, suggesting that enhanced cGMP-PDE activity may account for resistance to the natriuretic actions of ANP observed in vivo. This defect may represent the intrinsic sodium transport abnormality linked to sodium retention in nephrotic syndrome.Keywords
This publication has 36 references indexed in Scilit:
- Blunted excretory response to atrial natriuretic peptide in experimental nephrosisKidney International, 1989
- Atrial natriuretic peptide and the renal response to hypervolemia in nephrotic humansKidney International, 1988
- Extrarenal complications of the nephrotic syndromeKidney International, 1988
- Comparison of the natriuresis and chlorures is associated with glomerular hyperfiltration induced by atrial natriuretic factor or glucagonLife Sciences, 1987
- Effects of atrial natriuretic factor on cyclic guanosine monophosphate and cyclic adenosine monophosphate accumulation in microdissected nephron segments from rats.Journal of Clinical Investigation, 1987
- Functional relationships in the nephrotic syndromeKidney International, 1984
- EVIDENCE THAT SOME MECHANISM OTHER THAN THE RENIN SYSTEM CAUSES SODIUM RETENTION IN NEPHROTIC SYNDROMEThe Lancet, 1982
- Effects of water immersion on renal function in the nephrotic syndromeKidney International, 1982
- Functional adaptation of nephrons in dogs with acute progressing to chronic experimental glomerulonephritis.Journal of Clinical Investigation, 1976
- Effect of plasma albumin on sodium reabsorption in patients with nephrotic syndromeKidney International, 1972